The Next Generation Sequencing Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape etc. According to the report the Next Generation Sequencing Market is estimated to be $4.02 billion and predicted to rise to $10.69 billion with a CAGR of 21.6%. The market is segmented by Product (Software and Services), by technology (targeted re-sequencing, genome sequencing, de novo sequencing, exome sequencing, RNA-Seq, ChIP-Seq and Methyl-Seq), and application (diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture & animals research). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa
The next generation sequencing is anticipated to see the fastest growth owing to advancements in pre sequencing and bio-informatics solutions. Rise in growth of global population and increasing incidence of infectious diseases are the key factors driving the growth of global NGS market. However, the storage and management of data generated by sequencing and its interpretation, fall in capital expenditure from academic institutions are few factors hindering the growth of global next generation sequencing market
Targeted sequencing segment accounts for the largest share of the market due to the developments in whole genome sequencing capabilities. Under application diagnostic segment accounted for the largest share in 2015 while personalized medicine is estimated to be the fastest growing segment due to increasing emphasis on preventative measures during the forecast period.
North America is the largest market for next generation sequencing due to its high technological advancements and supporting government policies. Asia-pacific is the fastest growing market due to its wide population base and market penetration possibilities during the forecast period
The market is dominated by Illumina, which accounted for the largest market share of approximately 70%. Other major players in the market include Thermo Fischer Scientific, Life Sciences (Roche), Pacific Biosciences, Life Technologies Corp., Macrogen Inc.,Partek Inc., Genomatix Software GmbH, Perkin Elmer inc., GATC Biotech Ag, Agilent Technologies Inc., Biomatters Ltd., CLC Bio (Qiagen), BGI, Oxford Nanopore Technologies Ltd., Pacific Biosciences, DNASTAR Inc., Knome Inc., Illumina Inc., and Qiagen N.V.
Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-next-generation-sequencing-market-116/” and checkout our recent reports in the Biotechnology category at “http://www.marketdataforecast.com/research-reports/healthcare/biotechnology-3/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.